30.05.2013
- A strain of genetically engineered wheat never approved for sale or consumption was found sprouting on a farm in Oregon, the U.S. government said on Wednesday, and grain traders...
29.05.2013
- GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for €250 million ($321 million) - the latest bolt-on biotech buy...
29.05.2013
- Ready To Buy - Biomass as a resource for chemicals and plastics is on the rise. Drivers may differ - while some regions are looking for ways to commercialize their abundant biomass...
28.05.2013
- AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The...
23.05.2013
- Forest Laboratories said on Thursday that Howard Solomon, who has led the biotech firm since 1977, will retire as chief executive officer at the end of this year and the company...
23.05.2013
- The tide may have started to turn for initial public offerings from U.S. biotechnology companies, as a rising stock market, low interest rates and a lack of market volatility...
16.05.2013
- Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to the process told Reuters...
16.05.2013
- Monsanto, the world's largest seed company, is developing two new platforms that diverge from its core business and are seen as potential key long-term growth drivers, according to...
